Semaglutide deep-dive Semaglutide is sold under three brand names, all manufactured by Novo Nordisk: Ozempic -- weekly injection, FDA-approved for type 2 diabetes (doses 0.25 mg, 0.5 mg, 1 mg, 2 mg) Wegovy -- weekly injection, FDA-approved for chronic weight management in 2021 (doses up to 2.4 mg) [3] Rybelsus -- daily oral tablet, approved for type 2 diabetes For weight loss specifically, Wegovy is the on-label choice
It's more important to focus on general health gains, lifestyle changes, and long-term behaviors than on the number on the scale
The doses of Wegovy are seen to be cheaper than the doses of Mounjaro but not necessarily delivering the same average weight-loss percentage
However, little attention has been placed on the effects of semaglutide or other GLP1-RAs on cannabis consumption even though the prevalence of cannabis use is even higher than that of tobacco use among certain demographics
Split dosing
Lab Work: Before starting Semaglutide, we require a set of lab tests to ensure the treatment is safe and appropriate for you
